SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today ...
Vietnam Investment Review on MSN
Zuellig Pharma acquires Cialis rights in three Asian markets from Lilly
SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to ...
Zuellig Pharma acquires Cialis from Lilly in three additional markets in Asia: Singapore Saturday, March 14, 2026, 11:00 Hrs [IST] Zuellig Pharma, a leading healthcare solutions c ...
For eight years, Gillian Murphy dreaded cold weather. Winter would leave the 71-year-old's fingers white and freezing - while ...
For 150,000 shillings, Joel Obore promises more than just a quick fix; he promises a “permanent” transformation. Obore, a ...
This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Spoiler alert: You can stop TRT — but the way you do so ...
Penis Botox isn't all that uncommon these days and is chosen for a range of reasons. Tech entrepreneur Bryan Johnson revealed in March 2025 that he had incorporated Botox (as well as shockwave therapy ...
MedPage Today on MSN
Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements
Results with Optilume consistent in clinical trials and real world, regardless of prostate ...
Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...
Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial ...
While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results